Food scares and drug scandals have raised serious concerns over the F.D.A.’s ability to regulate effectively. A look at the resources and direction at the Food and Drug Administration, and why some are hoping for significant changes under the next administration.
science reporter for "The New York Times"
associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
director of the Health Research Group at Public Citizen; editor of WorstPills.org
U.S. Congresswoman, representing Connecticut's 3rd district; chairwoman of the Agriculture-FDA Appropriations Subcommittee
former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA